Ligand-Dependent Conformations and Dynamics of the Serotonin 5-HT2A Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties
Jufang Shan, George Khelashvili, Sayan Mondal, Ernest Louis Mehler, Harel Weinstein
PLoS Computational Biology April 19, 2012 DOI: 10.1371/journal.pcbi.1002473 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Computational molecular dynamics simulation study Peer reviewed |
|---|---|
| Population | Serotonin 2A receptor (5-HT(2A)R) model complexed with ligands in a membrane environment |
| Interventions | LSD Ketanserin |
| Topics | Serotonin |
| Citations | 109 |
| Key points | The authors report that serotonin, LSD, and ketanserin each induce different conformational states and dynamics in the serotonin 2A receptor, affecting the toggle switch W6.48, the ionic lock between E6.30 and R3.50, and the NPxxY motif. They propose a sequence of steps connecting these activation elements, and report that the three ligands produce different extents and patterns of membrane deformation, with cholesterol implicated in activation. The authors suggest these differences correlate with the ligands' distinct pharmacological properties and may relate to ligand-specific receptor oligomerization. |
Abstract
From computational simulations of a serotonin 2A receptor (5-HT(2A)R) model complexed with pharmacologically and structurally diverse ligands we identify different conformational states and dynamics adopted by the receptor bound to the full agonist 5-HT, the partial agonist LSD, and the inverse agonist Ketanserin. The results from the unbiased all-atom molecular dynamics (MD) simulations show that the three ligands affect differently the known GPCR activation elements including the toggle switch at W6.48, the changes in the ionic lock between E6.30 and R3.50 of the DRY motif in TM3, and the dynamics of the NPxxY motif in TM7. The computational results uncover a sequence of steps connecting these experimentally-identified elements of GPCR activation. The differences among the properties of the receptor molecule interacting with the ligands correlate with their distinct pharmacological properties. Combining these results with quantitative analysis of membrane deformation obtained with our new method (Mondal et al, Biophysical Journal 2011), we show that distinct conformational rearrangements produced by the three ligands also elicit different responses in the surrounding membrane. The differential reorganization of the receptor environment is reflected in (i)-the involvement of cholesterol in the activation of the 5-HT(2A)R, and (ii)-different extents and patterns of membrane deformations. These findings are discussed in the context of their likely functional consequences and a predicted mechanism of ligand-specific GPCR oligomerization.
Citations in the library
Cited by 5
- A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics Trends in Neurosciences December 21, 2020
- In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects Forensic Science International October 23, 2020
- Is there a place for psychedelics in sports practice? Acta Neuropsychiatrica 2025
- Deciphering the allosteric landscape of 5-HT2 receptors: integrated molecular dynamics and fragment molecular orbital analyses of activation mechanisms Pharmacological Reports September 25, 2026
- MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics. Physical chemistry chemical physics : PCCP July 1, 2026
Cites 9
- Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex Journal of Neuroscience October 1, 2003
- Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin. Journal of Biological Chemistry June 21, 1996
- Agonist-Trafficking and Hallucinogens Current Medicinal Chemistry March 1, 2009
- Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. Molecular Pharmacology 2003
- Serotonin 5- Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases Cardiovascular Psychiatry and Neurology October 13, 2009
and 4 more in the library